EP3114121
DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.3.2015EP published:
26.9.2018EP application number:
15710687.3
EPO information:
European Patent Register
Max expiry date:
4.3.2035
Title:
DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
Timeline
Today
5.3.2015EP application
26.9.2018EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
MENG, WeiAddress:
Pennington, New Jersey, US
Name:
ZHAO, GuohuaAddress:
Pennington, New Jersey, US
Priority
Number:
201461949506 PDate:
7.3.2014Country:
US
Classification
Categories:
C07D 401/14, C07D 401/04, C07D 409/04, C07D 409/14, C07D 417/14, A61K 31/4418, A61K 31/444, A61K 31/506, A61P 3/00, A61P 9/00